Via a tweet from Kyle Scott of Crossing Broad, we are led to this press release which, after I checked it out on the company’s website, appears to be legit:
FT. LAUDERDALE, Jan. 15, 2013 – Retired former Chicago Cubs sports legend and entrepreneur Sammy Sosa has purchased the distribution rights for North America and Latin America, excluding Brazil, for the needle-free injection system known as Injex21.
Mr. Sosa was introduced to the Injex system in mid-2012, when he immediately saw the potential to help millions of people around the world who are forced to take painful injections, who are afraid of injections or who subject themselves to daily self-injections. Medical workers, as well, can reduce the risk of puncture wounds.
I know nothing about this product, but if it helps anyone get needed medication easier, good for Sammy Sosa, no matter how many insanely easy punchlines it encourages.
Free agent first baseman Edwin Espinal has signed a minor league deal with the Tigers, the infielder announced Saturday. The move has yet to be confirmed by the team.
Espinal, 23, capped a seven-year run with the Pirates’ minor league affiliates in 2017. He split his season between Double-A Altoona and Triple-A Indianapolis, batting a cumulative .294/.327/.447 with 15 home runs and 31 doubles in 532 plate appearances. While he’s raked at nearly every level so far, he also profiles well on defense, and rounded off his 2017 performance with a perfect fielding percentage, 208 putouts and a Gold Glove award.
Espinal is untested at the major league level and it’s not yet clear if he’ll make the jump in 2018. He showed some positional versatility during his time in the minors, however, and could take reps at third base or DH if necessary. The Tigers are reportedly on the lookout for pitching depth and left-handed bats — two bills the right-handed Espinal doesn’t fit — and presumably have a lot of moves left to make this winter.